Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients.
Coleman
Craig I
CI
University of Connecticut School of Pharmacy, Storrs, USA.
Kalus
James S
JS
Caron
Michael F
MF
Kluger
Jeffrey
J
White
C Michael
CM
D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009010:Monte Carlo Method; D013449:Sulfonamides / Q000009:adverse effects*; D016171:Torsades de Pointes / Q000517:prevention & control*; D014481:United States
D000889:Anti-Arrhythmia Agents; D013449:Sulfonamides; C067192:ibutilide; D008274:Magnesium